Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026

Same author

Genome-Wide Identification of <i>BnaABI4</i> Genes and Their Roles in Regulating Stomatal Density and Drought Tolerance in <i>Brassica napus</i> L.

Plants (Basel, Switzerland)·2026

Same author

Organoids: From Bench to Bedside Applications.

MedComm·2026

Same author

Cross-Species Transmission and Structural Adaptive Evolution: Implications of the FCoV-23 Pandemic for the Evolution of Coronaviruses.

Advanced biology·2026

Same author

Comparing the Efficacy and Safety of Intra-articular Injection Treatments for Hip Osteoarthritis: A Systematic Review and Network Meta-analysis.

Orthopaedic journal of sports medicine·2026

Same author

The therapeutic potential of phage pT2784 against ST40-KL47 type <i>Acinetobacter baumannii</i> and bacterial fitness trade-offs.

Microbiology spectrum·2026

Search research articles

相关实验视频

Updated: Jan 10, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

由HSBDF衍生的生物活性成分通过向3C蛋白酶和减弱炎症反应,广泛抑制肠道病毒.

Ruolan Hu¹, Lin Guan², Siyue Li²

¹School of Life Sciences, Tianjin University, Tianjin 300072, China.

|November 27, 2025

概括

华夏百度配方 (HSBDF) 是一种传统的中医药,它对肠道病毒具有广泛的抗病毒活性. 在HSBDF中含有的三种黄胺抑制病毒复制和炎症,为新疗法提供了潜力.

关键词:

3C蛋白酶抑制剂是一种3C蛋白酶抑制剂.华夏百度公式 (HSBDF) 是一个这是一种抗炎药物.肠道病毒病毒.黄类化合物黄类化合物

更多相关视频

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

相关实验视频

Last Updated: Jan 10, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

科学领域:

病毒学病毒学
药理学药理学是指药理学的学科.
传统中国医药传统中国医药

背景情况:

人类肠道病毒导致全球重大健康问题,如手足口病和脑炎,没有特定的治疗方法.
传统中国医学 (TCM) 在COVID-19期间显示出抗病毒的前景,但其抗肠道病毒效应尚未得到充分理解.

研究的目的:

调查Huashi Baidu Formula (HSBDF) 的抗肠病毒活性,这是用于COVID-19的TCM.
确定HSBDF中的活性化合物并阐明它们的抗肠道病毒机制.

主要方法:

系统地描述HSBDF的抗肠道病毒活性.
转录学和高性能液体染色学-并联质谱学 (HPLC-MS/MS) 分析.
在体外测试病毒蛋白酶活性和炎症标志物.
使用小鼠模型进行体内研究.

主要成果:

HSBDF显示出广泛的抗肠道病毒活性.
三种类型的黄素 (维鲁丁,伊索拉姆尼丁, (-) - 甲酸盐) 被确定为关键活性成分.
HSBDF调节了MAPK和NF-κB通路,减少了CV-A9诱导的炎症.
这些黄类药物抑制了肠道病毒3C蛋白酶活性和关键炎症介导体.
在小鼠模型中,HSBDF和贝鲁丁抑制了病毒复制.

结论:

基于TCM的HSBDF是一种有前途的肠道病毒治疗策略.
黄化合物显示出作为广泛的抗肠道病毒药物的潜力.